Remove us-news medicare
article thumbnail

Listen: Pharma goes to Washington, Alnylam’s future, & Gilead’s dealmaking

STAT

The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election.

80
article thumbnail

Amneal Receives NDA Approval from the US FDA for Pemrydi RTU

PharmaShots

Shots: The US FDA has approved a 505(b)(2) NDA for Pemrydi RTU, the first ready-to-use presentation of pemetrexed indicated for use in combination with Keytruda and Pt-based CT for metastatic nonsq. Your go-to media platform for customized news ranging for multiple indications.

FDA 56
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Listen: SVB’s long biotech shadow, pushy AI algorithms, & Icahn v. Illumina

STAT

STAT reporter Bob Herman joins us to explain how treatment algorithms powered by artificial intelligence are being used more frequently by Medicare Advantage plans to deny claims, even when continued treatment is medically justified.

article thumbnail

STAT+: Pharmalittle: Genentech weighs delaying cancer therapy after drug pricing law; Novo continues to restrict supplies of low-dose Wegovy

STAT

As for us, we are immersed in the usual daily ritual — quaffing a few cups of stimulation. As always, please do keep us in mind if you hear something fascinating.  The news came as the drugmaker raised its full-year profit and sales forecasts for a second time. Our choice today is, once again, roasted coconut.

70
article thumbnail

Martin Short has a story to tell … about SingleCare savings

The Checkup by Singlecare

After learning about SingleCare in last year’s commercial, Martin Short is back in a new SingleCare commercial to spread the news about prescription savings with as many pharmacy customers as he can. The actor and comedian explains that you can get great prices on meds—even cheaper than your insurance copay or your Medicare plan price.

article thumbnail

Five for Friday January 12: Celebrating Success in Advancing Medication Use Quality

PQA

We also highlight our members' perspectives on patient monitoring tools, Medicare Advantage outcomes, and food insecurity. Medicare Advantage beneficiaries receiving value-based care were also more likely to adhere to their medications for conditions like diabetes and hypertension. Make plans to join us!

article thumbnail

Five for Friday April 5: Celebrating Success in Advancing Medication Use Quality

PQA

Yesterday, April 4, CMS issued the Contract Year 2025 Medicare Advantage and Part D Final Rule (CMS-4205-F). Attend the PQA Meeting to learn what's new in these programs and the implications of the new policies. Finalize Your Plans for the 2024 PQA Annual Meeting Finalize your plans to join us in Baltimore!